Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Diabetes. 2013 Jul;62(7):2460-70. doi: 10.2337/db12-0778. Epub 2013 Mar 14.
Harnessing control of human β-cell proliferation has proven frustratingly difficult. Most G1/S control molecules, generally presumed to be nuclear proteins in the human β-cell, are in fact constrained to the cytoplasm. Here, we asked whether G1/S molecules might traffic into and out of the cytoplasmic compartment in association with activation of cell cycle progression. Cdk6 and cyclin D3 were used to drive human β-cell proliferation and promptly translocated into the nucleus in association with proliferation. In contrast, the cell cycle inhibitors p15, p18, and p19 did not alter their location, remaining cytoplasmic. Conversely, p16, p21, and p27 increased their nuclear frequency. In contrast once again, p57 decreased its nuclear frequency. Whereas proliferating β-cells contained nuclear cyclin D3 and cdk6, proliferation generally did not occur in β-cells that contained nuclear cell cycle inhibitors, except p21. Dynamic cytoplasmic-nuclear trafficking of cdk6 was confirmed using green fluorescent protein-tagged cdk6 and live cell imaging. Thus, we provide novel working models describing the control of cell cycle progression in the human β-cell. In addition to known obstacles to β-cell proliferation, cytoplasmic-to-nuclear trafficking of G1/S molecules may represent an obstacle as well as a therapeutic opportunity for human β-cell expansion.
控制人类β细胞增殖已被证明是非常困难的。大多数 G1/S 控制分子,通常被认为是人类β细胞中的核蛋白,实际上都局限在细胞质中。在这里,我们想知道 G1/S 分子是否可能在细胞周期进程的激活过程中进出细胞质区室。使用 Cdk6 和 cyclin D3 来驱动人类β细胞增殖,它们会与增殖相关而迅速转位到核内。相比之下,细胞周期抑制剂 p15、p18 和 p19 并没有改变它们的位置,仍然存在于细胞质中。相反,p16、p21 和 p27 增加了它们的核频率。再次相反,p57 降低了其核频率。增殖的β细胞中含有核 cyclin D3 和 cdk6,但除了 p21 之外,含有核细胞周期抑制剂的β细胞通常不会发生增殖。使用绿色荧光蛋白标记的 cdk6 和活细胞成像技术,证实了 cdk6 的动态细胞质-核转运。因此,我们提供了描述人类β细胞细胞周期进程控制的新工作模型。除了已知的β细胞增殖障碍外,G1/S 分子的细胞质-核转运也可能代表一个障碍,同时也是人类β细胞扩增的治疗机会。